HYNR-CS-Allo
/ CoreStem
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 16, 2019
Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
(clinicaltrials.gov)
- P1; N=6; Completed; Sponsor: Hanyang University Seoul Hospital; Active, not recruiting ➔ Completed
Clinical • Trial completion
May 16, 2019
Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
(clinicaltrials.gov)
- P1; N=6; Active, not recruiting; Sponsor: Hanyang University Seoul Hospital; Recruiting ➔ Active, not recruiting; Trial completion date: Dec 2018 ➔ Oct 2021; Trial primary completion date: Nov 2018 ➔ Mar 2019
Clinical • Enrollment closed • Trial completion date • Trial primary completion date
1 to 2
Of
2
Go to page
1